- Adult OAB patients who present with OAB symptoms, including micturitions >= 8 per day
and urgency urinary incontinence >= 1 per day.
- Patient has known hypersensitivity to the active substance (fesoterodine fumarate) or
to peanut or soya or any of the excipients.
- Patient has a known neurological disease influencing bladder function.
- Patient has a complication of lower urinary tract pathology potentially responsible
for urgency or incontinence, clinically relevant bladder outlet obstruction or pelvic